[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578726":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":31,"responsibleParty":46,"collaborators":20,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":20,"eligibilityCriteria":53,"healthyVolunteers":50,"sex":54,"minAge":55,"maxAge":20,"enrollmentInfo":56,"targetDuration":20,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":65,"overallStatus":70,"whyStopped":20,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"CHA University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"PRP Treatment Arm","EXPERIMENTAL","Participants in this arm will receive autologous platelet-rich plasma (PRP) therapy for the treatment of elbow tendinopathy. The PRP is prepared from the patient's own blood and injected into the affected area to evaluate its clinical effectiveness. The study aims to analyze the relationship between PRP composition, including platelet concentration, white blood cell count, and specific growth factors, and treatment outcomes.",[13],"Biological: Autologous Platelet-Rich Plasma (PRP) Injection",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BIOLOGICAL","Autologous Platelet-Rich Plasma (PRP) Injection","Participants will receive autologous PRP injections prepared from their own blood to treat elbow tendinopathy. PRP is a plasma product with a 3-5 times higher platelet concentration than normal blood, containing growth factors such as TGF-β, PDGF, IGF, and EGF, which are known to promote tissue repair and regeneration. The PRP will be injected directly into the affected tendon area to evaluate its clinical effectiveness and the relationship between platelet concentration, growth factors, and treatment outcomes.",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Kyunghoon Min, MD, PhD.","CONTACT","82-31-780-1892","minkhrm@gmail.com",{"name":28,"role":24,"phone":29,"phoneExt":20,"email":30},"Younji Kim, MD","82-10-2876-3662","yunji0114@naver.com",[32],{"facility":33,"status":20,"city":34,"state":35,"zip":36,"country":37,"countryCode":20,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Bundang CHA Medical Center","Seongnam-si","Gyeonggi-do","13496","South Korea",{"type":39,"coordinates":40},"Point",[41,42],127.13778,37.43861,{"lat":42,"lon":41},[45],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},{"type":47,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100578726","phase-4-the-analysis-of-efficacy-factors-for-autologous-platelet-rich-plasma-therapy-in-the-treatment-of-elbow-tendinopathy-100578726",false,"NCT06815042","The Analysis of Efficacy Factors for Autologous Platelet-Rich Plasma Therapy in the Treatment of Elbow Tendinopathy","Inclusion Criteria:\n\n* Adults aged 19 years or older\n* Diagnosed with elbow tendinopathy\n* Persistent pain despite receiving conservative treatment\n\nExclusion Criteria:\n\n* Individuals with systemic infection at the time of study participation\n* Patients with rheumatic diseases or inflammatory disorders\n* Individuals with unstable systemic conditions affecting the cardiovascular, gastrointestinal, respiratory, or endocrine systems\n* Any other cases deemed inappropriate for study participation by the investigator","ALL","19 Years",{"count":57,"type":58},30,"ESTIMATED","INTERVENTIONAL",[61],"PHASE4","To identify key factors influencing the effectiveness of platelet-rich plasma (PRP) therapy in treating elbow tendinopathy, a common degenerative condition.",[64],"Elbow Tendinopathy",[66,67,68,69],"Platelet Rich Plasma","Protein Array Analysis","Growth factor","Patient-Rated Tennis Elbow Evaluation","NOT_YET_RECRUITING","2025-02-03",{"date":73,"type":74},"2025-02-07","ACTUAL",{"date":76,"type":58},"2025-02",{"date":78,"type":58},"2025-12",{"name":5,"class":6},1]